RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

DNA Funded vs ZoraFX

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

DNAF

DNA Funded

ZRFX

ZoraFX

DNA FUNDED

METRIC

ZORAFX

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

90%

—

MAX FUNDING

$200,000

—

MIN COST

$59

—

PAYOUT DAYS

10d

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

DNA FUNDED DETAILS

STEPS: -phase

ZORAFX DETAILS

STEPS: 2-phase
DRAWDOWN: Fixed
MARKETS: Forex
PLATFORMS: MT5

DNA Funded PROS

+No performance data is available to identify any above-average metrics for this firm
+No fee, payout, or structure data provided to evaluate competitiveness
+No platform or market data available to assess trading flexibility
+Country of operation (Australia) is noted, but no regulatory or structural data exists

DNA Funded CONS

−No data is provided for this firm, making any meaningful comparison impossible
−Traders cannot assess profit split, funding, or costs against the 84.7% and $186.7 averages
−Complete absence of data is a significant transparency concern for traders making financial decisions

ZoraFX PROS

+Profit split of 90% is well above the industry average of 84.7%, giving traders a significantly higher earnings share.
+Min challenge cost of $59 is well below the industry average of $186.7, making entry very affordable.
+Fee refund is offered, reducing the effective cost of the challenge upon successful completion.
+Weekend holding and news trading are both permitted, providing strong flexibility for trading strategies.

ZoraFX CONS

−Overall drawdown of 5% is below the industry average of 7.9%, providing less margin for drawdown before breach.
−Profit target of 10% is above the industry average of 7.9%, making the challenge harder to pass.
−Days to first payout at 10 is above the industry average of 6.5, meaning a longer wait for initial earnings.

PROPDNA VERDICT

DNA Funded

Higher trust score (0/100). Slower payouts at —d.

START WITH DNAF